The recent surge in calls to poison control hotlines related to GLP-1 overdosing or serious side effects should serve as a harbinger of what to expect as drug access becomes easier
Our society tends to be suspicious of new tools and interventions before we fully understand them
A study by researchers at the University of Pennsylvania found that people taking GLP-1 medications such as Ozempic, Wegovy, and Mounjaro faced a higher risk of developing alopecia than patients taking two other classes of diabetes drugs
It can be raised close to the dosage of Wegovy which so far leads to the most weight loss (about 15%) out of all the weight loss medications available in Canada today
[Crossref] [Google Scholar] [PubMed] Song J, Yao L, Shi J, Li J, Xu C
In fact, continuous application may be necessary to maintain benefits, similar to other hair restoration treatments